Table 2.
17 new loci | 49 established loci | 66 loci | |
---|---|---|---|
Minor allele frequency (mean, range) | 32.1% [5%-50%] | 28.9% [7%-49%] | 29.8% [5%-50%] |
Effect size SBP [mmHg] (range, mean) | 0.09-0.59, 0.34 | 0.07-1.13, 0.5 | 0.07-1.13, 0.46 |
Effect size DBP [mmHg] (range, mean) | 0.1-0.46, 0.23 | 0.06-0.60, 0.3 | 0.06-0.6, 0.28 |
Variance explained SBP | 0.52% | 2.95% | 3.46% |
Variance explained DBP | 0.58% | 2.78% | 3.36% |
Key characteristics of the novel and established BP loci are shown. MAF and effect size estimates are derived from the Cardio-MetaboChip data. Variance explained estimates are estimated from one large study (Supplementary Note). Novel loci are classified as previously unknown to be linked to BP by a systematic PubMed review of all genes in a 200kb window (Supplementary Note).